Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review
Frontiers in Cellular and Infection Microbiology · 19.11.2026 · 16
DOI: 10.3389/fcimb.2026.1934394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.11.2026. Verfasst von Athanasia Meimeteas und 1 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multidrug-resistant organism (MDRO) infections are a significant cause of morbidity and mortality in solid organ transplant recipients (SOTR), with multidrug-resistant gram-negative bacteria (MDRGNB) infections rising over the past decade. This mini review summarizes current evidence on the epidemiology, diagnostics, and mitigation strategies for MDRGNB in SOTR in the United States. Colonization, most commonly assessed via gastrointestinal surveillance, is dynamic and organism- and organ-dependent, with international meta-analytic data linking MDRO colonization to increased one-year mortality and over a tenfold increased risk of subsequent infection. Progression to active infection, particularly polymicrobial infection, further worsens outcomes, with effects varying by allograft type. Diagnostic approaches include phenotypic (culture-based) and genotypic (molecular) methods; culture-based antimicrobial susceptibility testing remains the gold standard, but delays targeted antibiotic treatment, while molecular assays offer faster turnaround, but are limited by an inability to assign resistance genes to specific pathogens. A combined phenotypic-genotypic approach is recommended for optimal detection of resistance. Proposed mitigation strategies, to date, include active surveillance and infection prevention, targeted perioperative antibiotic prophylaxis, antimicrobial stewardship guided by population-specific antibiograms, and emerging antibiotic-sparing approaches such as fecal microbiota transplant (FMT). Key gaps include the need for organ-specific management protocols, standardized screening practices, and expansion of pediatric and non-liver transplant recipient data.
Zitieren
APA
Meimeteas, A., & Thomas, S. J. (2026). Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1934394
Vancouver
Meimeteas A, Thomas SJ. Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1934394
BibTeX
@article{Meimeteas2026,
author = {Meimeteas, Athanasia and Thomas, Sanya J.},
title = {Landscape of multidrug resistant gram-negative bacteria among solid organ transplant recipients in the United States – a mini review},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1934394}
}
EUVIMED